Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels: a 12-week randomized trial (Q44004879)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2002

Language	Label	Description	Also known as
English	Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels: a 12-week randomized trial	scientific article published in June 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels: a 12-week randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Després JP

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Lemieux I

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Salomon H

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Delaval D

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

251

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

490-499

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Prevalence of risk factors in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.00988.X

21 January 2018

Identifiers

10.1046/J.1365-2796.2002.00988.X

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44004879&oldid=2105568614"